,X,Filing Date,Trade Date,Ticker,Insider Name,Title,Trade Type,Price,Qty,Owned,ΔOwn,Value,1d,1w,1m,6m,ticker
0,D,2022-02-25 16:05:49,2022-02-23,LYEL,Bishop Hans Edgar,Dir,M - OptEx,$0.10,993428,4540234,+28%,"+$99,343",,,,,LYEL
1,D,2021-06-23 18:14:59,2021-06-21,LYEL,Glaxosmithkline Plc,10%,C - Converted deriv,$0.00,30253189,30253189,-50%,$0,,,,,LYEL
2,D,2021-06-23 17:42:55,2021-06-21,LYEL,"Arch Venture Partners Ix, LLC",10%,C - Converted deriv,$0.00,36412716,36412716,-50%,$0,,,,,LYEL
3,D,2021-06-23 17:38:14,2021-06-21,LYEL,Nelsen Robert,"Dir, 10%",C - Converted deriv,$0.00,36412716,36412716,-50%,$0,,,,,LYEL
4,D,2021-06-23 17:36:41,2021-06-21,LYEL,Klausner Richard,Exec COB,C - Converted deriv,$0.00,3765842,6733676,-36%,$0,,,,,LYEL
5,D,2021-06-23 17:35:22,2021-06-21,LYEL,Bishop Hans Edgar,Dir,C - Converted deriv,$0.00,546806,3546806,-13%,$0,,,,,LYEL
6,D,2021-06-23 17:33:13,2021-06-21,LYEL,Friedman Cathy,Dir,C - Converted deriv,$0.00,3765842,3883490,-49%,$0,,,,,LYEL
7,D,2021-06-23 17:33:13,2021-06-21,LYEL,Friedman Cathy,Dir,P - Purchase,$17.00,17648,3883490,0%,"+$300,016",,,,,LYEL
